Google快讯 - lung cancer

	lung cancer 实时更新 ⋅ 2025年5月14日
	新闻
	Cheryl W. | American Lung Association American Lung Association The follow-up PET scan showed a 95% probability of lung cancer. I immediately quit smoking cold turkey. I got active, researched my insurance ... 标记为不相关
	New glow in the dark technology, Cytalux, helping remove cancer cells | FOX 13 Tampa Bay FOX 13 Tampa Bay When it comes to treating lung cancer, people often undergo surgery to remove the cancer, which starts with imaging studies. What they're saying: " ... 标记为不相关
	Peritoneal and small bowel metastasis from lung adenocarcinoma with EGFR L858R mutation Frontiers Approximately 40-50% of lung cancer patients present with metastases at the time of diagnosis, commonly affecting lymph nodes, liver, brain, adrenal ... 标记为不相关
	GSK, partner iTeos scrap development of lung cancer therapy - Westlaw Today Westlaw Today (Reuters) - Britain's GSK and drug developer iTeos Therapeutics said on Tuesday they have stopped developing an experimental lung cancer drug, ... 标记为不相关
	How NYU Langone's New Center for Molecular Oncology Is Transforming Cancer Care YouTube ... Cancer Center: https://nyulangone.org/locations/perlmutter-cancer ... What happens in every stage of lung cancer? | Cancer: Explained ... 标记为不相关
	Houston ranks No. 7 in most polluted cities, new report shows - ABC13 ABC13 ... pulmonary disease, and those who have lung cancer. What else? According to the ALA, air pollution's effects can include respiratory effects such ... 标记为不相关
	Median Technologies submits U.S. application for 510(k) clearance of eyonis® LCS Business Wire ... lung nodules in high-risk lung cancer populations, with significant potential to impact patients' clinical outcomes. Additionally, Median's eyonis ... 标记为不相关
	New AI Tool for Cancer Patient Stratification and Prediction - AZoRobotics AZoRobotics We validated this method using a real-world database of advanced small cell lung cancer patients treated with immune checkpoint inhibitors. Dr ... 标记为不相关
	TIGIT graveyard expands as GSK drops late-stage asset with iTeos - Endpoints News Endpoints News ... lung cancer data. Two months later, iTeos set aside one of its other pipeline drugs and went all in on the anti-TIGIT prospect, codenamed ... 标记为不相关
	Genetic insight into lung neuroendocrine tumors: Notch and Wnt signaling pathways as ... Journal of Translational Medicine - BioMed Central A comparison of germline and somatic mutations is critical to identifying putative tumor driver mutations. In perspective, the enrichment of a ... 标记为不相关
查看更多结果 | 修改此快讯

您收到此电子邮件是因为您订阅了Google快讯。 退订 | 查看您所有的快讯

以RSS Feed的形式接收此快讯

发送反馈